---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-24-036620"
form_type: "8-K"
ticker: "SNWV"
cik: "0001417663"
company_name: "SANUWAVE Health, Inc."
filed_at: "2024-08-09T23:59:59+00:00"
generated_at: "2026-05-31T10:21:24.564535+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Shareholders approve reverse stock split (1:300-1:500) and 2024 Equity Plan with 516M shares

## Summary
- Proposal 1: Reverse stock split authorized at ratio of 1-for-300 to 1-for-500, with final ratio set by Board.
- Proposal 2: 2024 Equity Incentive Plan approved, authorizing up to 516,208,834 shares of common stock.
- Both proposals passed with overwhelming stockholder support: ~96% for reverse split, ~96% for equity plan.
- No further awards will be made under the prior 2006 Stock Incentive Plan.

## SEC filing metadata
- accession: 0001140361-24-036620
- form_type: 8-K
- ticker: SNWV
- cik: 0001417663
- company_name: SANUWAVE Health, Inc.
- filed_at: 2024-08-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1417663/000114036124036620/0001140361-24-036620-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1417663/000114036124036620/ef20033849_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-24-036620
- JSON: https://secwatch.observer/filing/0001140361-24-036620.json
- Plain text: https://secwatch.observer/filing/0001140361-24-036620.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.